Business
Join Cannabics Pharmaceuticals at the National Cannabis Industry Association's Cannabis Business Summit and Expo Held at San Jose Convention Center, California USA, July 25-27, 2018
Join Cannabics Pharmaceuticals at the National Cannabis Industry Association's Cannabis Business Summit and Expo Held at San Jose Convention Center, California USA, July 25-27, 2018.
About this update from Cnbx Pharmaceuticals Inc.
[{"type":"text","content":"\n\n\n\nJoin Cannabics Pharmaceuticals at the National Cannabis Industry Association's Cannabis Business Summit and Expo Held at San Jose Convention Center, California USA, July 25-27, 2018\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nJoin Cannabics Pharmaceuticals at the National Cannabis Industry Association's Cannabis Business Summit and Expo Held at San Jose Convention Center, California USA, July 25-27, 2018\nPR Newswire\nTEL AVIV, Israel and BETHESDA, Maryland, July 11, 2018\n\n\n\nTEL AVIV, Israel and BETHESDA, Maryland, July 11, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that senior members of its team will be attending the National Cannabis Industry Association Business Conference and Expo, to be held in San Jose convention center, California, USA, on July 25th-27th 2018, and will be available for one on one meetings.\n\n\nThe National Cannabis Industry Association, or NCIA, is the industry's premier organization in the United States, and the Business conference and expo held in San Jose is their 5th and largest event to date. The event brings together professionals in various fields within the cannabis sector in the USA.\n\nIn attendance will be Mr. Eyal Barad, Co-Founder and CEO, alongside Mr. Noam Permont, VP of Business Development. \n\nEyal Barad, CEO of the company, said: \"We are looking forward to meeting and collaborating with fellow cannabis industry members. Considering the recent approval of a cannabis-based medicine by the FDA, we believe that our ability to network and collaborate in this evolving environment will prove instrumental to our efforts to introduce additional cannabis-based medicines and therapies into mainstream medicine in the future.\"  \n\nMr. Barad and Mr. Permont will be accepting 1 on 1 meetings and are available at [email protected]\n\nAbout Cannabics Pharmaceuticals  Cannabics Pharmaceuticals Inc. (CNBX) is a United States-based public company that...